Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
SK Biopharmaceuticals. (326030.KQ) Q2 2026 Earnings
326030.KQ
7
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
349.08
802.9
1,256.71
1,710.53
Details
Expected EPS
464.6559689712
Actual EPS
1267.1636388023999
Surprise EPS
802.51
Surprise Percent
+172.71%
Description
SK Biopharmaceuticals. (326030.KQ) has reported earnings of 1267.1636388023999 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login